Paragon 28 (FNA) Competitors

Paragon 28 (NYSE:FNA) and Inari Medical (NASDAQ:NARI) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, community ranking, dividends and analyst recommendations.

Do insiders & institutionals have more ownership in FNA or NARI?

63.6% of Paragon 28 shares are held by institutional investors. Comparatively, 91.0% of Inari Medical shares are held by institutional investors. 15.3% of Paragon 28 shares are held by insiders. Comparatively, 10.6% of Inari Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Do analysts prefer FNA or NARI?

Paragon 28 presently has a consensus target price of $15.60, suggesting a potential upside of 50.72%. Inari Medical has a consensus target price of $58.89, suggesting a potential upside of 20.18%. Given Paragon 28's stronger consensus rating and higher possible upside, equities research analysts clearly believe Paragon 28 is more favorable than Inari Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Paragon 28	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Inari Medical	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.45

Is FNA or NARI more profitable?

Inari Medical has a net margin of -13.68% compared to Paragon 28's net margin of -25.31%. Inari Medical's return on equity of -10.09% beat Paragon 28's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Paragon 28	-25.31%	-37.90%	-18.22%
Inari Medical	-13.68%	-10.09%	-6.60%

Does the MarketBeat Community believe in FNA or NARI?

Inari Medical received 32 more outperform votes than Paragon 28 when rated by MarketBeat users. However, 82.50% of users gave Paragon 28 an outperform vote while only 61.90% of users gave Inari Medical an outperform vote.

Company	Underperform	Outperform
Paragon 28	Outperform Votes 33 82.50%	Underperform Votes 7 17.50%
Inari Medical	Outperform Votes 65 61.90%	Underperform Votes 40 38.10%

Which has higher earnings and valuation, FNA or NARI?

Inari Medical has higher revenue and earnings than Paragon 28. Inari Medical is trading at a lower price-to-earnings ratio than Paragon 28, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Paragon 28	$216.39M	4.00	-$57.53M	-$0.74	-13.99
Inari Medical	$493.63M	5.81	-$1.64M	-$1.35	-36.30

Does the media favor FNA or NARI?

In the previous week, Paragon 28 had 19 more articles in the media than Inari Medical. MarketBeat recorded 27 mentions for Paragon 28 and 8 mentions for Inari Medical. Inari Medical's average media sentiment score of 1.02 beat Paragon 28's score of 0.13 indicating that Inari Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Paragon 28	2 Very Positive mention(s)	2 Positive mention(s)	19 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Inari Medical	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, FNA or NARI?

Paragon 28 has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500. Comparatively, Inari Medical has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500.

Summary

Inari Medical beats Paragon 28 on 9 of the 17 factors compared between the two stocks.